Početna › Karcinom hipofarinksa
Kliničke studije za Karcinom hipofarinksa koje traže sudionike u SAD-u
19 studija za Karcinom hipofarinksa traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Atlanta, GA6 studija
- Chicago, IL6 studija
- Stevens Point, WI5 studija
- Joliet, IL5 studija
- Peoria, IL5 studija
- Bloomington, IL5 studija
- Wausau, WI5 studija
- Richmond, VA5 studija
- Cape Girardeau, MO5 studija
- Milwaukee, WI5 studija
- Kansas City, MO5 studija
- New York City, NY4 studija
- Edison, NJ4 studija
- Queens, NY4 studija
- Waukegan, IL4 studija
- Green Bay, WI4 studija
- Cedar Rapids, IA4 studija
- Evanston, IL4 studija
- Danville, IL4 studija
- Fargo, ND4 studija
- Lansing, MI4 studija
- Omaha, NE4 studija
- Champaign, IL4 studija
- Decatur, IL4 studija
- Aurora, IL4 studija
- St. Louis, MO4 studija
- Galesburg, IL4 studija
- Naperville, IL4 studija
- Flint, MI4 studija
- Oklahoma City, OK4 studija
- Charleston, IL4 studija
- Cicero, IL4 studija
- North Peoria, IL4 studija
- Waterford, MI4 studija
- Bozeman, MT4 studija
- Duluth, MN4 studija
- Pittsburgh, PA4 studija
- Baltimore, MD4 studija
- Cincinnati, OH4 studija
- Louisville, KY4 studija
Po državama
- Arizona3 studija
- Arkansas4 studija
- Colorado6 studija
- Florida8 studija
- Georgia6 studija
- Idaho3 studija
- Illinois7 studija
- Indiana4 studija
- Iowa6 studija
- Kalifornija7 studija
- Kansas6 studija
- Kentucky4 studija
- Maryland5 studija
- Massachusetts5 studija
- Michigan5 studija
- Minnesota6 studija
- Missouri6 studija
- Montana4 studija
- Nebraska4 studija
- New Jersey4 studija
- New York8 studija
- North Carolina5 studija
- North Dakota4 studija
- Ohio8 studija
- Oklahoma4 studija
- Oregon3 studija
- Pennsylvania6 studija
- South Dakota3 studija
- Texas3 studija
- Virginia5 studija
- Wisconsin6 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06997068BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05136196Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT05172245Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT07441681Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 29. srp 2026. · NCT04198766Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 16. srp 2026. · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 15. srp 2026. · NCT01365169Integrated Cancer Repository for Cancer Research
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 15. tra 2026. · NCT03010150TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 4. ožu 2026. · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 19. velj 2026. · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 11. velj 2026. · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 10. velj 2026. · NCT01473784Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
U tijeku regrutacijaRana faza 1
Od 18 godina i više · Oba spola · Ažurirano 22. lis 2025. · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
U tijeku regrutacijaOpažajna studija
Od 21 do 90 godina · Oba spola · Ažurirano 22. ruj 2025. · NCT00900419Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.